Spectral Medical Inc T.EDT

News Dump

[hmmmmmmmm]

Spectral's Friday news dump is up on Sedar.

This "News Release" looks like the soft ball version to distract us from the real MD&A.

Looks like 7 more documents filed with a ton more info to go through.

I'd recommend all investors go to Sedar.com 

[hmmmmmmmm]

Some early standouts... “With the investment in iDialco, Spectral is no longer focused on the dialysis device market, and therefore the Dialco operations were considered discontinued as at December 31, 2022.”   “It was difficult to accurately budget for the cost of completing the DIMI Trial, but Spectral expected costs to exceed $10,000. In order to pursue and complete the DIMI Trial

[hmmmmmmmm]

4 times MD&A mentions increases due to "severance costs". Like this mention of an almost 1.3million dollar increase. "The increase of $1,297 was due primarily to severance costs and increased professional services." Would this be Sam Amory severance pay?  If so Seto answer to this.  On May 16th Sam was hired on as President of Dialco, and by early October

[hmmmmmmmm]

Looks like the CRO was just another party to blame. In Spectral's Oct. 15 "Short Form Preliminary Prospectus" they stated: "The clinical trial is being managed internally by the Company, an independent contract research organization, and third-party logistics support."  In today's release Kellum says:  "Importantly, we are in the process of